XP Chemistries AB
XP Chemistries AB (publ), a biotechnology company, engages in the development and production of forest-based capsaicin and analogues. It offers animal feed ingredients; personal care and cosmetic ingredients; pure capsaicinoids; and self-defense spray ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.
XP Chemistries AB (XPC) - Net Assets
Latest net assets as of September 2025: Skr39.57 Million SEK
Based on the latest financial reports, XP Chemistries AB (XPC) has net assets worth Skr39.57 Million SEK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr40.66 Million) and total liabilities (Skr1.09 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr39.57 Million |
| % of Total Assets | 97.32% |
| Annual Growth Rate | 236.31% |
| 5-Year Change | 371.63% |
| 10-Year Change | N/A |
| Growth Volatility | 3570.46 |
XP Chemistries AB - Net Assets Trend (2019–2024)
This chart illustrates how XP Chemistries AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for XP Chemistries AB (2019–2024)
The table below shows the annual net assets of XP Chemistries AB from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr21.56 Million | -16.05% |
| 2023-12-31 | Skr25.69 Million | -11.63% |
| 2022-12-31 | Skr29.07 Million | -7.13% |
| 2021-12-31 | Skr31.30 Million | +584.56% |
| 2020-12-31 | Skr4.57 Million | +9044.90% |
| 2019-12-31 | Skr50.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to XP Chemistries AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2574687800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr4.86 Million | 22.53% |
| Other Components | Skr42.45 Million | 196.86% |
| Total Equity | Skr21.56 Million | 100.00% |
XP Chemistries AB Competitors by Market Cap
The table below lists competitors of XP Chemistries AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AKS Corporation Public Company Limited
BK:AKS
|
$2.35 Million |
|
Arcadia Biosciences Inc
NASDAQ:RKDA
|
$2.35 Million |
|
ARHT Media Inc
OTCQB:ARHTF
|
$2.35 Million |
|
HIKARI TSUSHIN
MU:HIK
|
$2.35 Million |
|
Nl Development Public Company Limited
BK:NL
|
$2.35 Million |
|
NEVADA SUNRISE METALS
F:K4L
|
$2.35 Million |
|
Element79 Gold Corp
OTCQB:ELMGF
|
$2.35 Million |
|
QEM Ltd
AU:QEM
|
$2.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in XP Chemistries AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 25,687,897 to 21,564,945, a change of -4,122,952 (-16.1%).
- Net loss of 7,133,622 reduced equity.
- New share issuances of 2,846,744 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-7.13 Million | -33.08% |
| Share Issuances | Skr2.85 Million | +13.2% |
| Other Changes | Skr163.93K | +0.76% |
| Total Change | Skr- | -16.05% |
Book Value vs Market Value Analysis
This analysis compares XP Chemistries AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.93x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 59.41x to 0.93x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | Skr0.00 | Skr0.19 | x |
| 2020-12-31 | Skr0.29 | Skr0.19 | x |
| 2021-12-31 | Skr2.04 | Skr0.19 | x |
| 2022-12-31 | Skr0.94 | Skr0.19 | x |
| 2023-12-31 | Skr0.82 | Skr0.19 | x |
| 2024-12-31 | Skr0.20 | Skr0.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently XP Chemistries AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -33.08%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2512.39%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.05x
- Recent ROE (-33.08%) is below the historical average (-30.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -47.22% | -5806.11% | 0.01x | 1.14x | Skr-2.62 Million |
| 2021 | -14.52% | -1626.81% | 0.01x | 1.10x | Skr-7.68 Million |
| 2022 | -27.23% | -749.81% | 0.03x | 1.05x | Skr-10.82 Million |
| 2023 | -31.29% | -1211.26% | 0.02x | 1.06x | Skr-10.61 Million |
| 2024 | -33.08% | -2512.39% | 0.01x | 1.05x | Skr-9.29 Million |
Industry Comparison
This section compares XP Chemistries AB's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $76,555,000
- Average return on equity (ROE) among peers: -11.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| XP Chemistries AB (XPC) | Skr39.57 Million | -47.22% | 0.03x | $2.35 Million |
| Serstech AB (SERT) | $76.56 Million | -11.93% | 0.24x | $8.34 Million |